↓ Skip to main content

The impact of prostate‐specific antigen level at diagnosis on the relative survival of 28,531 men with localized carcinoma of the prostate

Overview of attention for article published in Cancer (0008543X), February 2008
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (77th percentile)
  • Good Attention Score compared to outputs of the same age and source (74th percentile)

Mentioned by

blogs
1 blog

Citations

dimensions_citation
33 Dimensions

Readers on

mendeley
18 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The impact of prostate‐specific antigen level at diagnosis on the relative survival of 28,531 men with localized carcinoma of the prostate
Published in
Cancer (0008543X), February 2008
DOI 10.1002/cncr.23235
Pubmed ID
Authors

Gabriel Sandblom, Sam Ladjevardi, Hans Garmo, Eberhard Varenhorst

Abstract

To evaluate the predictive value of prostate-specific antigen (PSA) in a population-based cohort, the authors analyzed relative survival in all men with localized prostate cancer who were registered in the Swedish National Prostate Cancer Register (NPCR) from 1996 to 2005.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 18 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 18 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 3 17%
Other 3 17%
Student > Doctoral Student 2 11%
Student > Ph. D. Student 2 11%
Professor > Associate Professor 2 11%
Other 5 28%
Unknown 1 6%
Readers by discipline Count As %
Medicine and Dentistry 12 67%
Unspecified 1 6%
Immunology and Microbiology 1 6%
Nursing and Health Professions 1 6%
Unknown 3 17%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 August 2014.
All research outputs
#6,754,661
of 25,374,917 outputs
Outputs from Cancer (0008543X)
#5,455
of 14,096 outputs
Outputs of similar age
#37,485
of 172,957 outputs
Outputs of similar age from Cancer (0008543X)
#16
of 63 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. This one has received more attention than most of these and is in the 73rd percentile.
So far Altmetric has tracked 14,096 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.4. This one has gotten more attention than average, scoring higher than 60% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 172,957 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 77% of its contemporaries.
We're also able to compare this research output to 63 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.